top of page
Recent Posts
See AllRakovina Therapeutics has obtained exclusive rights to compounds from the Enki™ platform and the option to license validated drug candidates
The company’s performance during this period reflects remarkable growth and strategic focus on optimizing operations.
AI model will revolutionize facility management Edmonton, Alberta – May 21, 2024 – Visionstate Corp. (TSXV: VIS) (“Visionstate” or the...
bottom of page
Comments